Crossmark

Preclinical evaluation of pentagamavunone-1 as monotherapy and combination therapy for pancreatic cancer in multiple xenograft models

Published Online: 2022-12-27

Authors

Kamitani, Naoki

Nakamae, Ikuko

Yoneda-Kato, Noriko

Kato, Jun-ya

Sho, Masayuki
License Information

Text and Data Mining valid from 2022-12-27

Version of Record valid from 2022-12-27
More Information

Article History

Received: 30 September 2022

Accepted: 21 December 2022

First Online: 27 December 2022

Competing interests

: The authors declare no competing interests.

Document is current